Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.37 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | P2RX1 | P51575 | 2/20 | 0.31 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.31 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29612167 | 1.00 | HDAC3 (0.41) | HDAC3HSD17B3PARP1TSHRNOTUM | |
| Hydrochloric Acid SCHEMBL28318725 | 0.98 | HDAC3 (0.40) | HDAC3HSD17B3PARP1TSHRNOTUM | |
| SCHEMBL114181 | 0.78 | HDAC3 (0.38) | HDAC3HSD17B3PARP1TSHRNOTUM | |
| SCHEMBL3069885 | 0.77 | HDAC3 (0.43) | HDAC3HSD17B3PARP1TSHRCA1 | |
| SCHEMBL9902397 | 0.76 | MEN1 (0.34) | MEN1KMT2A | |
| SCHEMBL30385312 | 0.74 | HDAC3 (0.41) | HDAC3HSD17B3PARP1TSHRNOTUM | |
| SCHEMBL13932579 | 0.74 | HDAC3 (0.38) | HDAC3HSD17B3PARP1NOTUMCA1 | |
| SCHEMBL143063 | 0.74 | HDAC3 (0.38) | HDAC3HSD17B3PARP1CA1CA2 | |
| SCHEMBL11353696 | 0.74 | HDAC3 (0.38) | HDAC3HSD17B3PARP1CA1CA2 | |
| SCHEMBL1564351 | 0.74 | HDAC3 (0.41) | HDAC3HSD17B3PARP1TSHRNOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4322948-A1 | METHODS FOR THE ADMINISTRATION OF CERTAIN VMAT2 INHIBITORS | Neurocrine Biosciences, Inc. (US) | 2024-02-21 | — | — | EP | claimed |
| EP-4322934-A1 | METHODS FOR THE COMBINED ADMINISTRATION OF DEUTETRABENAZINE AND A CYP2D6 INHIBITOR | Neurocrine Biosciences, Inc. (US) | 2024-02-21 | — | — | EP | claimed |
| CN-117479938-A | Methods of administering certain VMAT2 inhibitors | 纽罗克里生物科学有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-112209823-B | Method for preparing geranic acid by oxidizing citral | 万华化学集团股份有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-114679906-A | Methods of administering specific VMAT2 inhibitors to patients with severe renal impairment | 纽罗克里生物科学有限公司 | 2022-06-28 | — | — | CN | claimed |
| CN-112209823-A | Method for preparing geranic acid by oxidizing citral | 万华化学集团股份有限公司 | 2021-01-12 | — | — | CN | claimed |
| CN-108925135-A | Synthetic method for preparing (S) - (2R,3R,11bR) -3-isobutyl-9, 10-dimethoxy-2, 3,4,6,7,11 b-hexahydro-1H-pyrido [2,1-a ] isoquinolin-2-yl-2-amino-3-methylbutyrate bis (4-methylbenzenesulfonate) | 纽罗克里生物科学有限公司 | 2018-11-30 | — | — | CN | claimed |
| CN-106456629-A | Vmat2 inhibitors for the treatment of hyperkinetic movement disorders | 纽罗克里生物科学有限公司 | 2017-02-22 | — | — | CN | claimed |
| CN-106061506-A | Pharmaceutical compositions comprising an antipsychotic agent and a VMAT2 inhibitor and uses thereof | 纽罗克里生物科学有限公司 | 2016-10-26 | — | — | CN | claimed |
| CN-102271716-A | Synthesis from tosylate precursors18F-radiolabelled styrylpyridines and stable pharmaceutical compositions thereof | — | 2011-12-07 | — | — | CN | claimed |
| US-20060156485-A1 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | THE PROCTER & GAMBLE COMPANY (US) | 2006-07-20 | — | — | US | claimed |
| EP-1431984-A1 | Polymer resistor composition having a substantially neutral temperature coefficient of resistance and methods and compositions relating thereto | E. I. du Pont de Nemours and Company (US) | 2004-06-23 | — | — | EP | claimed |
| US-20040113127-A1 | Resistor compositions having a substantially neutral temperature coefficient of resistance and methods and compositions relating thereto | E.I. DU PONT DE NEMOURS AND COMPANY | 2004-06-17 | — | — | US | claimed |
| US-4055712-A | CONDENSATION OF A TERTIARY AMINE WITH 1,4-DIHALO-2-BUTENE, QUATERNIZATION | KAWANEE INDUSTRIES (US) | 1977-10-25 | — | — | US | claimed |
| CN-117642165-A | Valphenazine for the additional treatment of schizophrenia | 纽罗克里生物科学有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-114539243-B | Novel deuterium-substituted Positron Emission Tomography (PET) imaging agent and pharmacological application thereof | 五一一制药股份有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-117479938-A | Methods of administering certain VMAT2 inhibitors | 纽罗克里生物科学有限公司 | 2024-01-30 | — | — | CN | disclosed |
| US-4520025-A | ANTIULCER AND ANTISECRETORY AGENTS: | WILLIAM H. RORER, INC. (US) | 1985-05-28 | — | — | US | disclosed |
| US-4339396-A | Process for the preparation of naphthalenesulphonyl chloride | BAYER AKTIENGESELLSCHAFT (DE) | 1982-07-13 | — | — | US | disclosed |
| US-4055712-A | CONDENSATION OF A TERTIARY AMINE WITH 1,4-DIHALO-2-BUTENE, QUATERNIZATION | KAWANEE INDUSTRIES (US) | 1977-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060156485-A1 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | KRT18, TUBB6, DNMT1 | HDAC3 418/4885HSD17B3 1275/4885PARP1 919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.